BetterLife Pharma Inc. Stock Other OTC
Equities
BETRF
CA08772P2026
Biotechnology & Medical Research
Sales 2022 | - | Sales 2023 | - | Capitalization | 13.32M 18.13M |
---|---|---|---|---|---|
Net income 2022 | -12M -16.34M | Net income 2023 | -9M -12.26M | EV / Sales 2022 | - |
Net Debt 2022 | 139K 189K | Net Debt 2023 | 71.69K 97.63K | EV / Sales 2023 | - |
P/E ratio 2022 |
-1.26
x | P/E ratio 2023 |
-1.36
x | Employees | - |
Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 77.36% |
Managers | Title | Age | Since |
---|---|---|---|
Ahmad Doroudian
CEO | Chief Executive Officer | 63 | 07-09-16 |
Moira Ong
DFI | Director of Finance/CFO | 49 | 10-12-25 |
Chief Operating Officer | 67 | - |
Members of the board | Title | Age | Since |
---|---|---|---|
Ahmad Doroudian
CEO | Chief Executive Officer | 63 | 07-09-16 |
Robert Metcalfe
BRD | Director/Board Member | 84 | 20-01-20 |
Wolfgang Renz
BRD | Director/Board Member | 54 | 15-02-04 |
1st Jan change | Capi. | |
---|---|---|
+8.29% | 113B | |
+10.21% | 106B | |
+0.41% | 22.27B | |
-11.90% | 22.22B | |
-5.99% | 19.43B | |
-37.36% | 17.87B | |
-5.17% | 17.24B | |
+7.70% | 14.29B | |
+37.65% | 12.52B |